Bryan Sisk

ARDVARC-Advancing Rare Disorders: Vascular mAlformation Research Network with CaNVAS

National Heart, Lung, and Blood Institute · U54

Project lead · $806.9K · Children's Hosp of Philadelphia

Cancer Care Companion: An Electronic Health Record Tool to Improve Information Exchange and Self-Management in Pediatric Cancer

National Cancer Institute · R21

Contact PI · $411.7K · Washington University

Cancer Care Companion

Principal investigator · Recruiting

Washington University School of Medicine

EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)

Site PI · Recruiting · Phase 2

Novartis Pharmaceuticals

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

Site PI · Recruiting · Phase 2

National Cancer Institute (NCI)

Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.

Site PI · Recruiting · Phase 2, Phase 3

Novartis Pharmaceuticals